127. J BUON. 2018 May-Jun;23(3):835.Is it rational to extend the duration of preventive endocrine treatment inhormone receptor positive ductal carcinoma in situ?Altundag K(1).Author information: (1)MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.PMID: 30003760 